Literature DB >> 25895968

Anti-Pseudomonas aeruginosa IgY Antibodies Induce Specific Bacterial Aggregation and Internalization in Human Polymorphonuclear Neutrophils.

K Thomsen1, L Christophersen1, T Bjarnsholt2, P Ø Jensen1, C Moser1, N Høiby3.   

Abstract

Polymorphonuclear neutrophils (PMNs) are essential cellular constituents in the innate host response, and their recruitment to the lungs and subsequent ubiquitous phagocytosis controls primary respiratory infection. Cystic fibrosis pulmonary disease is characterized by progressive pulmonary decline governed by a persistent, exaggerated inflammatory response dominated by PMNs. The principal contributor is chronic Pseudomonas aeruginosa biofilm infection, which attracts and activates PMNs and thereby is responsible for the continuing inflammation. Strategies to prevent initial airway colonization with P. aeruginosa by augmenting the phagocytic competence of PMNs may postpone the deteriorating chronic biofilm infection. Anti-P. aeruginosa IgY antibodies significantly increase the PMN-mediated respiratory burst and subsequent bacterial killing of P. aeruginosa in vitro. The mode of action is attributed to IgY-facilitated formation of immobilized bacteria in aggregates, as visualized by fluorescence microscopy and the induction of increased bacterial hydrophobicity. Thus, the present study demonstrates that avian egg yolk immunoglobulins (IgY) targeting P. aeruginosa modify bacterial fitness, which enhances bacterial killing by PMN-mediated phagocytosis and thereby may facilitate a rapid bacterial clearance in airways of people with cystic fibrosis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25895968      PMCID: PMC4468541          DOI: 10.1128/IAI.02970-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Antibody structure and molecular immunology.

Authors:  G M Edelman
Journal:  Scand J Immunol       Date:  1991-07       Impact factor: 3.487

Review 2.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

Review 3.  Bacterial manipulation of innate immunity to promote infection.

Authors:  Lautaro Diacovich; Jean-Pierre Gorvel
Journal:  Nat Rev Microbiol       Date:  2010-02       Impact factor: 60.633

4.  Cell surface hydrophobicity and adherence of a strain of group B streptococci during the post-antibiotic effect of penicillin.

Authors:  Angela Maria Mendes Araújo; Ivi Cristina Menezes de Oliveira; Marcos Corrêa de Mattos; Leslie C Benchetrit
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2008 Jul-Aug       Impact factor: 1.846

5.  Analysis of neutrophil bactericidal activity.

Authors:  Jessie N Green; Christine C Winterbourn; Mark B Hampton
Journal:  Methods Mol Biol       Date:  2007

6.  Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection.

Authors:  A Kharazmi; P O Schiøtz; N Høiby; L Baek; G Döring
Journal:  Eur J Clin Invest       Date:  1986-04       Impact factor: 4.686

7.  Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  G Taccetti; S Campana; F Festini; M Mascherini; G Döring
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

8.  Effect of subinhibitory concentrations of antibiotics on the adhesion of Streptococcus pyogenes to pharyngeal epithelial cells.

Authors:  S Tylewska; S Hjertén; T Wadström
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

Review 9.  How human neutrophils kill and degrade microbes: an integrated view.

Authors:  William M Nauseef
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

10.  Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease.

Authors:  G Döring; W Goldstein; K Botzenhart; A Kharazmi; P O Schiøtz; N Høiby; M Dasgupta
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

View more
  12 in total

1.  Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against Pseudomonas aeruginosa Infection.

Authors:  Fatemeh Norouzi; Bahador Behrouz; Mahya Ranjbar; Seyed Latif Mousavi Gargari
Journal:  J Immunol Res       Date:  2020-05-29       Impact factor: 4.818

2.  Anti-lipopolysaccharide egg yolk antibodies enhance the phagocytosis of mammalian phagocytes.

Authors:  Xin Zhou; Siyuan Ma
Journal:  Biol Open       Date:  2018-06-20       Impact factor: 2.422

Review 3.  IgY antibodies for the immunoprophylaxis and therapy of respiratory infections.

Authors:  Aymn Talat Abbas; Sherif Aly El-Kafrawy; Sayed Sartaj Sohrab; Esam Ibraheem Ahmed Azhar
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

4.  The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells.

Authors:  Heni Susilowati; Sidna Artanto; Heribertus Dedy Kusuma Yulianto; Wihaskoro Sosroseno; Suryani Hutomo
Journal:  F1000Res       Date:  2019-07-04

5.  Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection.

Authors:  Abolfazl Jahangiri; Parviz Owlia; Iraj Rasooli; Jafar Salimian; Ehsan Derakhshanifar; Zahra Aghajani; Sajad Abdollahi; Saeed Khalili; Daryush Talei; Elham Darzi Eslam
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

6.  A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases.

Authors:  Anna-Karin Jonsson; Anders Larsson; Thomas Tängdén; Åsa Melhus; Anders Lannergård
Journal:  Infect Ecol Epidemiol       Date:  2015-11-09

7.  Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes.

Authors:  Signe M Nielsen; Niels Nørskov-Lauritsen; Thomas Bjarnsholt; Rikke L Meyer
Journal:  Microorganisms       Date:  2016-09-14

Review 8.  IgY - turning the page toward passive immunization in COVID-19 infection (Review).

Authors:  Carolina Constantin; Monica Neagu; Teodora Diana Supeanu; Viorica Chiurciu; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2020-04-30       Impact factor: 2.447

9.  Production and characteristics of a novel chicken egg yolk antibody (IgY) against periodontitis-associated pathogens.

Authors:  Xiangguang Li; Pan He; Linjin Yu; Qiyi He; Chenggang Jia; Huiyi Yang; Minglei Lu; Xiuting Wei; Suqing Zhao
Journal:  J Oral Microbiol       Date:  2020-10-12       Impact factor: 5.474

Review 10.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.